MAP3K2-regulated intestinal stromal cells define a distinct stem cell niche

Ningbo Wu,Hongxiang Sun,Xiaoyun Zhao,Yao Zhang,Jianmei Tan,Yuanyuan Qi,Qun Wang,Melissa Ng,Zhaoyuan Liu,Lingjuan He,Xiaoyin Niu,Lei Chen,Zhiduo Liu,Hua-Bing Li,Yi Arial Zeng,Manolis Roulis,Dou Liu,Jinke Cheng,Bin Zhou,Lai Guan Ng,Duowu Zou,Youqiong Ye,Richard A. Flavell,Florent Ginhoux,Bing Su

DOI: https://doi.org/10.1038/s41586-021-03283-y

IF: 64.8

2021-03-03

Nature

Abstract:Intestinal stromal cells are known to modulate the propagation and differentiation of intestinal stem cells^{<a href="/articles/s41586-021-03283-y#ref-CR1">1</a>,<a href="/articles/s41586-021-03283-y#ref-CR2">2</a>}. However, the precise cellular and molecular mechanisms by which this diverse stromal cell population maintains tissue homeostasis and repair are poorly understood. Here we describe a subset of intestinal stromal cells, named MAP3K2-regulated intestinal stromal cells (MRISCs), and show that they are the primary cellular source of the WNT agonist R-spondin 1 following intestinal injury in mice. MRISCs, which are epigenetically and transcriptomically distinct from subsets of intestinal stromal cells that have previously been reported^{<a href="#ref-CR3">3</a>,<a href="#ref-CR4">4</a>,<a href="#ref-CR5">5</a>,<a href="/articles/s41586-021-03283-y#ref-CR6">6</a>}, are strategically localized at the bases of colon crypts, and function to maintain LGR5⁺ intestinal stem cells and protect against acute intestinal damage through enhanced R-spondin 1 production. Mechanistically, this MAP3K2 specific function is mediated by a previously unknown reactive oxygen species (ROS)–MAP3K2–ERK5–KLF2 axis to enhance production of R-spondin 1. Our results identify MRISCs as a key component of an intestinal stem cell niche that specifically depends on MAP3K2 to augment WNT signalling for the regeneration of damaged intestine.

multidisciplinary sciences

What problem does this paper attempt to address?

The paper aims to address the following issues:

1. **Understanding the role of MAP3K2-regulated intestinal stromal cells (MRISCs)**: The study investigates a specific subset of intestinal stromal cells (MRISCs) that are the primary source of the WNT agonist R-spondin 1 following intestinal injury in mice. By enhancing the production of R-spondin 1, MRISCs are able to maintain the number of LGR5+ intestinal stem cells (ISCs) and protect them from acute damage.

2. **Revealing the mechanism of MAP3K2 in the intestinal stem cell microenvironment**: Through a series of experiments, researchers discovered that MAP3K2 enhances the production of R-spondin 1 via a previously unknown reactive oxygen species (ROS)-MAP3K2-ERK5-KLF2 axis. This mechanism is crucial for the regeneration of the damaged intestine.

3. **Exploring the in vivo effects of MAP3K2 on intestinal stem cells**: By comparing wild-type mice and MAP3K2 knockout mice in a dextran sulfate sodium (DSS)-induced colitis model, the study found that the absence of MAP3K2 leads to a reduction in the number of intestinal stem cells, further confirming the important role of MAP3K2 in protecting intestinal stem cells.

In summary, this paper aims to reveal how MAP3K2-regulated intestinal stromal cells (MRISCs) protect and maintain the function of intestinal stem cells through specific mechanisms and to explore their specific role in the intestinal repair process.